# Efficacy of Riluzole in Hereditary Cerebellar Ataxia

> **NCT01104649** · PHASE2,PHASE3 · COMPLETED · sponsor: **S. Andrea Hospital** · enrollment: 60 (actual)

## Conditions studied

- Cerebellar Ataxia

## Interventions

- **DRUG:** riluzole
- **DRUG:** Placebo comparator

## Key facts

- **NCT ID:** NCT01104649
- **Lead sponsor:** S. Andrea Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2014-02
- **Final completion:** 2014-03
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01104649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01104649, "Efficacy of Riluzole in Hereditary Cerebellar Ataxia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01104649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*